» Articles » PMID: 20056882

CRISPR/Cas, the Immune System of Bacteria and Archaea

Overview
Journal Science
Specialty Science
Date 2010 Jan 9
PMID 20056882
Citations 989
Authors
Affiliations
Soon will be listed here.
Abstract

Microbes rely on diverse defense mechanisms that allow them to withstand viral predation and exposure to invading nucleic acid. In many Bacteria and most Archaea, clustered regularly interspaced short palindromic repeats (CRISPR) form peculiar genetic loci, which provide acquired immunity against viruses and plasmids by targeting nucleic acid in a sequence-specific manner. These hypervariable loci take up genetic material from invasive elements and build up inheritable DNA-encoded immunity over time. Conversely, viruses have devised mutational escape strategies that allow them to circumvent the CRISPR/Cas system, albeit at a cost. CRISPR features may be exploited for typing purposes, epidemiological studies, host-virus ecological surveys, building specific immunity against undesirable genetic elements, and enhancing viral resistance in domesticated microbes.

Citing Articles

Current Landscape and Future Directions in Cancer Immunotherapy: Therapies, Trials, and Challenges.

Bandara S, Raveendran S Cancers (Basel). 2025; 17(5).

PMID: 40075668 PMC: 11899461. DOI: 10.3390/cancers17050821.


CRISPR/Cas9-Targeted Deletion Improves the Myogenic Differentiation Parameters for Muscle-Derived Stem Cells in Mice.

Elashry M, Schneider V, Heimann M, Wenisch S, Arnhold S J Dev Biol. 2025; 13(1).

PMID: 39982358 PMC: 11843916. DOI: 10.3390/jdb13010005.


Towards an Evolutionary Model of Animal-Associated Microbiomes.

Yeoman C, Chia N, Yildirim S, Miller M, Kent A, Stumpf R Entropy (Basel). 2025; 13(3):570-594.

PMID: 39963611 PMC: 11831856. DOI: 10.3390/e13030570.


Advancements in genome editing tools for genetic studies and crop improvement.

Ahmadikhah A, Zarabizadeh H, Nayeri S, Abbasi M Front Plant Sci. 2025; 15:1370675.

PMID: 39963359 PMC: 11830681. DOI: 10.3389/fpls.2024.1370675.


Combining CRISPR activation and interference capabilities using dCas9 and G-quadruplex structures.

Kabir M, Kodikara S, Hoque M, Shiekh S, Alfehaid J, Basu S NAR Mol Med. 2025; 2(1):ugaf001.

PMID: 39906285 PMC: 11788920. DOI: 10.1093/narmme/ugaf001.